Patents by Inventor Christopher KEMBALL

Christopher KEMBALL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230057263
    Abstract: Provided herein are single-chain polypeptides and multi-chain polypeptides that bind specifically to CD3 epsilon (CD3?). Also provided herein are anti-idiotypic antibodies that bind specifically to any of the antigen-binding domains described herein.
    Type: Application
    Filed: January 6, 2021
    Publication date: February 23, 2023
    Applicant: CYTOMX THERAPEUTICS, INC.
    Inventors: Christopher KEMBALL, Pia CHALLITA-EID, Rene HUBERT